Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 2/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7816405 | 0.73 | ALDH1A1 (0.45) | FDPSTHRBHSD17B10 | |
| SCHEMBL3225195 | 0.73 | FDPS (0.48) | FDPSMAPTANPEPERAP2MMP2 | |
| Ammonia Solution, Strong SCHEMBL786750 | 0.72 | ALDH1A1 (0.44) | FDPSTHRBHSD17B10 | |
| SCHEMBL4410158 | 0.70 | FDPS (0.50) | FDPSMAPTANPEPERAP2MMP2 | |
| SCHEMBL18149022 | 0.70 | FDPS (0.35) | FDPSMAPTATMANPEPERAP2 | |
| SCHEMBL8928325 | 0.68 | LAP3 (0.53) | ANPEPERAP2 | |
| SCHEMBL4407985 | 0.67 | FDPS (0.47) | FDPSANPEPERAP2 | |
| SCHEMBL4736414 | 0.67 | ANPEP (0.38) | FDPSANPEPERAP2 | |
| SCHEMBL898693 | 0.67 | FDPS (0.75) | FDPSANPEPERAP2KDM4EMMP2 | |
| SCHEMBL203348 | 0.67 | FDPS (0.75) | FDPSANPEPERAP2KDM4EMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5593659-A | IN THE FORM OF PHYSIOLOGICALLY ACCEPTABLE SALTS; MEDICAL DIAGNOSIS; WATER SOLUBLE, NONTOXIC | CONCAT, LTD. (US) | 1997-01-14 | — | — | US | disclosed |
| EP-0513000-B1 | MRI IMAGE ENHANCEMENT OF BONE AND RELATED TISSUE USING COMPLEXES OF PARAMAGNETIC CATIONS AND POLYPHOSPHONATE LIGANDS | CONCAT LTD (US) | 1996-07-31 | — | — | EP | disclosed |
| US-5380515-A | CONTRAST | CONCAT, LTD. (US) | 1995-01-10 | — | — | US | disclosed |
| US-5236695-A | Medical diagnosis | CONCAT, LTD. (US) | 1993-08-17 | — | — | US | disclosed |
| EP-0513000-A1 | MRI IMAGE ENHANCEMENT OF BONE AND RELATED TISSUE USING COMPLEXES OF PARAMAGNETIC CATIONS AND POLYPHOSPHONATE LIGANDS. | CONCAT LTD (US) | 1992-11-19 | — | — | EP | disclosed |
| EP-0513000-A4 | MRI IMAGE ENHANCEMENT OF BONE AND RELATED TISSUE USING COMPLEXES OF PARAMAGNETIC CATIONS AND POLYPHOSPHONATE LIGANDS. | CONCAT LTD (US) | 1992-09-01 | — | — | EP | disclosed |
| WO-1991007911-A1 | MRI IMAGE ENHANCEMENT OF BONE AND RELATED TISSUE USING COMPLEXES OF PARAMAGNETIC CATIONS AND POLYPHOSPHONATE LIGANDS | CONCAT LTD. (US) | 1991-06-13 | — | — | WO | disclosed |